A meningitis vaccine does not protect against gonorrhea spread between men, a new clinical trial has concluded. Experts had hoped that a meningococcal B vaccine called 4CMenB might prevent the spread ...

A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...

AUSTIN, TX - March 19, 2026 - Published research in Molecular Psychiatry evaluating folinic acid supplementation in ...

This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from ...

Calculator could streamline assessment and standardize urine testing in febrile preverbal children in emergency departments.

A retrospective pooled analysis of 1,100 patients demonstrates the Nodify CDT® test’s consistent clinical performance across nodule sizes and patient populations ...

The trial will examine the efficacy, safety, and pharmacodynamics of S-606001 SRT used with ERT in confirmed LOPD adults.

The 5-year recurrence rates, incidence of incisional hernias, and quality-of-life outcomes did not differ significantly ...

Urinary stone disease is common, associated with substantial morbidity, has a high recurrence rate, and affects quality of life.1,2 Consumption of large volumes of fluids is a foundational strategy ...

Findings from two early clinical studies suggest a new dual-action antimalarial drug candidate is well tolerated in humans. The first-in-class clinical candidate, MK7602, is being developed by WEHI ...

Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating JSKN016, a novel TROP2/HER3 bispecific ...

The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...